Abstract
AbstractBackgroundPeople with severe COVID anxiety have significant fears of contagion, physiological symptoms of anxiety in response to a COVID stimuli, and employ safety behaviours which are often in excess of health guidelines and at the expense of other life priorities. The natural course of severe COVID anxiety is not known.MethodsThis prospective cohort study followed 285 people with severe COVID anxiety in United Kingdom over 18-months. Descriptive statistics and linear regression models identified factors associated with change in COVID anxiety.ResultsMost participants experienced major reductions in COVID anxiety over time (69.8% relative cohort mean decrease; p<0.001), but a quarter of people (23.7%, 95% CI 17.8 to 30.1) continued to worry about COVID every day. Increasing age, being from an ethnic background which conferred greater risk from COVID-19, and the persistence of high levels of health anxiety and depressive symptoms predicted significantly slower improvements in severe COVID anxiety adjusting for other clinical and demographic factors.ConclusionsFor most people severe COVID anxiety significantly improves with time. However established interventions treating depression or health anxiety, and targeting older people and people from at-risk minority groups who appear to recover at slower rates, might be clinically indicated in future pandemics.HighlightsMost people with severe COVID anxiety reported large improvements in symptoms 18-months later.Levels of co-occurring poor mental health and social functioning also improved for most people.More than 1 in 10 continued to have severe COVID anxiety symptoms 18 months later.Age, ethnic background, and high levels of health anxiety and depression predict slower improvements.People with these risk characteristics could be considered for targeted support.
Publisher
Cold Spring Harbor Laboratory